<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font26 { font-size : 26; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">hepatitis </span>
   <span class="font30">HCV </span>
   <span class="font26">virus </span>
   <span class="font22">resistance </span>
   <span class="font20">treatment </span>
   <span class="font19">patients </span>
   <span class="font19">genotype </span>
   <span class="font18">antiviral </span>
   <span class="font18">testing </span>
   <span class="font17">NSA </span>
   <span class="font17">viral </span>
   <span class="font17">{border-style </span>
   <span class="font16">chronic </span>
   <span class="font16">clinical </span>
   <span class="font16">considered </span>
   <span class="font16">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">drug </span>
   <span class="font15">infection </span>
   <span class="font15">protein </span>
   <span class="font15">Hepatitis </span>
   <span class="font15">RAS </span>
   <span class="font15">recommended </span>
   <span class="font14">RASs </span>
   <span class="font14">NSB </span>
   <span class="font14">inhibitor </span>
   <span class="font14">therapy </span>
   <span class="font14">Virol </span>
   <span class="font14">polymerase </span>
   <span class="font14">protease </span>
   <span class="font13">DAA </span>
   <span class="font13">cirrhosis </span>
   <span class="font13">replication </span>
   <span class="font13">Genotype </span>
   <span class="font13">However, </span>
   <span class="font13">substitutions </span>
   <span class="font13">DAAs </span>
   <span class="font13">management </span>
   <span class="font13">proteins </span>
   <span class="font13">ribavirin </span>
   <span class="font13"> NSA </span>
   <span class="font12">NS/A </span>
   <span class="font12">Table </span>
   <span class="font12">infected </span>
   <span class="font12">prevalence </span>
   <span class="font12">px; </span>
   <span class="font12">therapy. </span>
   <span class="font12">variants </span>
   <span class="font12">{font-family </span>
   <span class="font12">RNA </span>
   <span class="font12">cell </span>
   <span class="font12">drugs </span>
   <span class="font12">font-size </span>
   <span class="font12">genotypes </span>
   <span class="font12">important </span>
   <span class="font12">inhibitors </span>
   <span class="font12">review </span>
   <span class="font12">role </span>
   <span class="font12">agents </span>
   <span class="font12">amino </span>
   <span class="font12">associated </span>
   <span class="font12">common </span>
   <span class="font12">different </span>
   <span class="font12">double; </span>
   <span class="font12">emerging </span>
   <span class="font12">interferon </span>
   <span class="font12">presence </span>
   <span class="font12">present, </span>
   <span class="font12">reported </span>
   <span class="font12">sequencing </span>
   <span class="font12">treatment-naive </span>
   <span class="font12">viruses </span>
   <span class="font12">vitro </span>
   <span class="font12">weeks </span>
   <span class="font11">Med </span>
   <span class="font11">Nonstructural </span>
   <span class="font11">SVR </span>
   <span class="font11">Structural </span>
   <span class="font11">Viral </span>
   <span class="font11">acid </span>
   <span class="font11">acting </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">direct </span>
   <span class="font11">direct-acting </span>
   <span class="font11">dominant </span>
   <span class="font11">epidemiology </span>
   <span class="font11">existing </span>
   <span class="font11">global </span>
   <span class="font11">healthcare </span>
   <span class="font11">like </span>
   <span class="font11">nucleotide </span>
   <span class="font11">present </span>
   <span class="font11">rates </span>
   <span class="font11">result </span>
   <span class="font11">solid; </span>
   <span class="font11">standard </span>
   <span class="font11">used </span>
   <span class="font11">weight-based </span>
   <span class="font11">wild-type </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11"> RAS </span>
   <span class="font11">-infected, </span>
   <span class="font11">Clin </span>
   <span class="font11">Europe </span>
   <span class="font11">Europe, </span>
   <span class="font11">Gastroenterol </span>
   <span class="font11">High </span>
   <span class="font11">India, </span>
   <span class="font11">Liver </span>
   <span class="font11">Low </span>
   <span class="font11">a-infected, </span>
   <span class="font11">action </span>
   <span class="font11">analysis </span>
   <span class="font11">barrier </span>
   <span class="font11">bold </span>
   <span class="font11">clinically </span>
   <span class="font11">core </span>
   <span class="font11">courier; </span>
   <span class="font11">develop </span>
   <span class="font11">em; </span>
   <span class="font11">generation </span>
   <span class="font11">hepatic </span>
   <span class="font11">high </span>
   <span class="font11">lower </span>
   <span class="font11">new </span>
   <span class="font11">nonstructural </span>
   <span class="font11">plus </span>
   <span class="font11">potency </span>
   <span class="font11">potential </span>
   <span class="font11">prevalent </span>
   <span class="font11">primary </span>
   <span class="font11">pt;} </span>
   <span class="font11">quasispecies </span>
   <span class="font11">region </span>
   <span class="font11">relevance </span>
   <span class="font11">replicative </span>
   <span class="font11">ribavirin, </span>
   <span class="font11">services </span>
   <span class="font11">treatment-experienced </span>
   <span class="font11">various </span>
  </p>
 </body>
</html>
